| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 263.78B | 260.79B | 241.59B | 221.28B | 201.79B | 190.81B |
| Gross Profit | 44.50B | 42.68B | 37.89B | 27.75B | 18.86B | 12.36B |
| EBITDA | 66.76B | 66.05B | 64.80B | 50.72B | 41.01B | 32.66B |
| Net Income | 23.38B | 22.50B | 23.93B | 14.62B | 4.02B | -1.86B |
Balance Sheet | ||||||
| Total Assets | 991.86B | 976.88B | 950.65B | 935.11B | 920.98B | 962.23B |
| Cash, Cash Equivalents and Short-Term Investments | 43.22B | 43.08B | 43.29B | 38.41B | 36.97B | 41.86B |
| Total Debt | 448.96B | 435.82B | 433.49B | 475.85B | 483.73B | 507.34B |
| Total Liabilities | 657.37B | 648.65B | 643.54B | 660.52B | 660.26B | 703.66B |
| Stockholders Equity | 317.20B | 311.21B | 292.58B | 261.12B | 248.00B | 246.50B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 7.47B | 31.83B | 6.14B | 18.64B | -15.42B |
| Operating Cash Flow | 0.00 | 43.81B | 62.22B | 39.09B | 41.88B | 21.34B |
| Investing Cash Flow | 0.00 | -39.30B | -10.53B | -26.30B | -19.67B | -33.27B |
| Financing Cash Flow | 0.00 | -4.79B | -46.83B | -11.34B | -27.03B | 35.82B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
78 Outperform | ¥344.63B | 9.85 | ― | 1.61% | 6.55% | -12.49% | |
73 Outperform | ¥249.51B | 4.69 | 12.70% | 1.68% | 8.29% | 24.94% | |
72 Outperform | ¥611.07B | 8.33 | 13.92% | 1.50% | 6.30% | -16.29% | |
66 Neutral | ¥1.42T | 10.37 | 11.29% | 3.00% | 5.48% | 33.67% | |
65 Neutral | ¥609.91B | 12.46 | 8.51% | 2.96% | -2.82% | -50.73% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
62 Neutral | ¥576.94B | 5.46 | 9.94% | 2.49% | 1.72% | 10.19% |